weight loss center semaglutide Medicare expands availability for GLP-1 drugs. A KU doctor explains what to know | KCUR Semaglutide Therapy: Transforming Weight Loss

At this time, there is not enough scientific evidence to consider it safe for use during pregnancy or breastfeeding, so avoiding it during these stages is generally recommended

Key Takeaways: Most people experience mild nausea, low energy, or a shift in appetite in the first week

Symptom Reduction: Many patients report a reduction in the daily pain, heaviness, and swelling of their limbs, even if the volume of the legs hasn't changed drastically

Compounding pharmacies will be allowed to continue to compound tirzepatide for now, but it remains to be seen how long they will be able to do so and if they will be able to continue to do so by adding additional ingredients to differentiate their product from the non-compounded, non-approved version

Victoria, speaking: And they were originally designed to help patients with Type 2 diabetes